The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

While Ozempic (semaglutide) can help manage blood sugar in type 2 diabetes or assist in weight management, it also has the risk of causing some serious side effects. If you are prescribed Ozempic, you ...

It combines semaglutide with another molecule, called cagrilintide, which intensifies the hormone-mimicking effects to regulate blood sugar and reduce hunger. Spencer was intrigued.

Medicare drug plans usually cover the pill form of semaglutide for type 2 diabetes. Learn more about coverage and costs.

Novo Nordisk will increase Wegovy access through a WeightWatchers partnership and a new self-pay opportunity, according to a news release published today. Beginning July 1, 2025, obesity patients will ...

Type 1 AID users get a boost from semaglutide The first study of its kind presented evidence that a combination of AID and semaglutide (Ozempic for diabetes, Wegovy for weight management) can ...

New research suggests that semaglutide, the active ingredient in GLP-1 drugs like Ozempic and Wegovy, might protect against dementia.

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

Novo Nordisk A/S: Ozempic® receives EU recommendation in peripheral arterial disease, cementing the broad benefits of semaglutide for people with type 2 diabetes and comorbidities ...

Semaglutide, a common diabetes and weight loss medication, can have several long-term side effects. Despite this, experts generally consider it safe and effective.